The MYC axis in advanced prostate cancer is impacted through concurrent targeting of ERβ and AR using a novel ERβ-selective ligand alongside Enzalutamide
Preprint in bioRxiv (November 2023)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Preprint in bioRxiv (November 2023)
Article in International Journal of Molecular Sciences (October 2023)
Article in Neuroscience & Biobehavioral Reviews (February 2023)